Answers are grounded in this paper and cite their sources.
Pharmacological inhibition shows effectiveness against FLT3-mutated acute myeloid leukemia, suggesting a new treatment option.
Ataxia telangiectasia mutations and RAD3-related (ATR) kinase supports cancer cell survival via managing DNA damage or replication stress in various cancers, including acute myeloid leukemia (AML). Pharmacological inhibition of ATR...
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: